Does proton pump inhibitor (PPI) therapy increase the risk of fractures?

MOspace/Manakin Repository

Breadcrumbs Navigation

Does proton pump inhibitor (PPI) therapy increase the risk of fractures?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/11027

[+] show full item record


Title: Does proton pump inhibitor (PPI) therapy increase the risk of fractures?
Author: Spensley, Kayla; Kraus, Connie
Keywords: bone fracture
Date: 2011-06
Publisher: Family Physicians Inquiries Network
Citation: Evidence Based Practice 14(6): 10-11.
Series/Report no.: Help Desk Answers
Abstract: In the absence of other risk factors, PPI use is not associated with an increased risk of hip fractures, osteoporosis, or loss of bone mineral density (BMD) at the hip or spine. (SOR: B, based on case-controlled and cohort studies.)
URI: http://hdl.handle.net/10355/11027

This item appears in the following Collection(s)

[+] show full item record